Study shows ivonescimab improves progression-free survival in EGFR+ lung cancer

1 year ago 79

For patients with non-small cell lung cancer with the epidermal growth factor receptor (EGFR) variant, ivonescimab plus chemotherapy improves progression-free survival, according to a study published ...

1. Homepage
2. Lung Cancer
3. Study shows ivonescimab improves progression-free survival in EGFR+ lung cancer